Global Infant and Child Multiple Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Infant and Child Multiple Vaccine market size was valued at US$ million in 2022. With growing demand in downstream market, the Infant and Child Multiple Vaccine is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Infant and Child Multiple Vaccine market. Infant and Child Multiple Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infant and Child Multiple Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infant and Child Multiple Vaccine market.
The process of upgrading global multi-vaccine products is a process of solidifying the competitive landscape.
Key Features:
The report on Infant and Child Multiple Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infant and Child Multiple Vaccine market. It may include historical data, market segmentation by Type (e.g., Pentavalent Vaccine, Quadruple Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infant and Child Multiple Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infant and Child Multiple Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infant and Child Multiple Vaccine industry. This include advancements in Infant and Child Multiple Vaccine technology, Infant and Child Multiple Vaccine new entrants, Infant and Child Multiple Vaccine new investment, and other innovations that are shaping the future of Infant and Child Multiple Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infant and Child Multiple Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Infant and Child Multiple Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infant and Child Multiple Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infant and Child Multiple Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infant and Child Multiple Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infant and Child Multiple Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infant and Child Multiple Vaccine market.
Market Segmentation:
Infant and Child Multiple Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Infant and Child Multiple Vaccine market?
What factors are driving Infant and Child Multiple Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infant and Child Multiple Vaccine market opportunities vary by end market size?
How does Infant and Child Multiple Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Infant and Child Multiple Vaccine market size was valued at US$ million in 2022. With growing demand in downstream market, the Infant and Child Multiple Vaccine is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Infant and Child Multiple Vaccine market. Infant and Child Multiple Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infant and Child Multiple Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infant and Child Multiple Vaccine market.
The process of upgrading global multi-vaccine products is a process of solidifying the competitive landscape.
Key Features:
The report on Infant and Child Multiple Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infant and Child Multiple Vaccine market. It may include historical data, market segmentation by Type (e.g., Pentavalent Vaccine, Quadruple Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infant and Child Multiple Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infant and Child Multiple Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infant and Child Multiple Vaccine industry. This include advancements in Infant and Child Multiple Vaccine technology, Infant and Child Multiple Vaccine new entrants, Infant and Child Multiple Vaccine new investment, and other innovations that are shaping the future of Infant and Child Multiple Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infant and Child Multiple Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Infant and Child Multiple Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infant and Child Multiple Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infant and Child Multiple Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infant and Child Multiple Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infant and Child Multiple Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infant and Child Multiple Vaccine market.
Market Segmentation:
Infant and Child Multiple Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Pentavalent Vaccine
- Quadruple Vaccine
- Triple Vaccine
- Others
- 12 Months Below
- 12 Months Above
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
What is the 10-year outlook for the global Infant and Child Multiple Vaccine market?
What factors are driving Infant and Child Multiple Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infant and Child Multiple Vaccine market opportunities vary by end market size?
How does Infant and Child Multiple Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infant and Child Multiple Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Infant and Child Multiple Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Infant and Child Multiple Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Infant and Child Multiple Vaccine Segment by Type
2.2.1 Pentavalent Vaccine
2.2.2 Quadruple Vaccine
2.2.3 Triple Vaccine
2.2.4 Others
2.3 Infant and Child Multiple Vaccine Sales by Type
2.3.1 Global Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Infant and Child Multiple Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Infant and Child Multiple Vaccine Sale Price by Type (2018-2023)
2.4 Infant and Child Multiple Vaccine Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Infant and Child Multiple Vaccine Sales by Application
2.5.1 Global Infant and Child Multiple Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Infant and Child Multiple Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Infant and Child Multiple Vaccine Sale Price by Application (2018-2023)
3 GLOBAL INFANT AND CHILD MULTIPLE VACCINE BY COMPANY
3.1 Global Infant and Child Multiple Vaccine Breakdown Data by Company
3.1.1 Global Infant and Child Multiple Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Infant and Child Multiple Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Infant and Child Multiple Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Infant and Child Multiple Vaccine Revenue by Company (2018-2023)
3.2.2 Global Infant and Child Multiple Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Infant and Child Multiple Vaccine Sale Price by Company
3.4 Key Manufacturers Infant and Child Multiple Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infant and Child Multiple Vaccine Product Location Distribution
3.4.2 Players Infant and Child Multiple Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFANT AND CHILD MULTIPLE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Infant and Child Multiple Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Infant and Child Multiple Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Infant and Child Multiple Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Infant and Child Multiple Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Infant and Child Multiple Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Infant and Child Multiple Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Infant and Child Multiple Vaccine Sales Growth
4.4 APAC Infant and Child Multiple Vaccine Sales Growth
4.5 Europe Infant and Child Multiple Vaccine Sales Growth
4.6 Middle East & Africa Infant and Child Multiple Vaccine Sales Growth
5 AMERICAS
5.1 Americas Infant and Child Multiple Vaccine Sales by Country
5.1.1 Americas Infant and Child Multiple Vaccine Sales by Country (2018-2023)
5.1.2 Americas Infant and Child Multiple Vaccine Revenue by Country (2018-2023)
5.2 Americas Infant and Child Multiple Vaccine Sales by Type
5.3 Americas Infant and Child Multiple Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infant and Child Multiple Vaccine Sales by Region
6.1.1 APAC Infant and Child Multiple Vaccine Sales by Region (2018-2023)
6.1.2 APAC Infant and Child Multiple Vaccine Revenue by Region (2018-2023)
6.2 APAC Infant and Child Multiple Vaccine Sales by Type
6.3 APAC Infant and Child Multiple Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infant and Child Multiple Vaccine by Country
7.1.1 Europe Infant and Child Multiple Vaccine Sales by Country (2018-2023)
7.1.2 Europe Infant and Child Multiple Vaccine Revenue by Country (2018-2023)
7.2 Europe Infant and Child Multiple Vaccine Sales by Type
7.3 Europe Infant and Child Multiple Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infant and Child Multiple Vaccine by Country
8.1.1 Middle East & Africa Infant and Child Multiple Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Infant and Child Multiple Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Infant and Child Multiple Vaccine Sales by Type
8.3 Middle East & Africa Infant and Child Multiple Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infant and Child Multiple Vaccine
10.3 Manufacturing Process Analysis of Infant and Child Multiple Vaccine
10.4 Industry Chain Structure of Infant and Child Multiple Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infant and Child Multiple Vaccine Distributors
11.3 Infant and Child Multiple Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFANT AND CHILD MULTIPLE VACCINE BY GEOGRAPHIC REGION
12.1 Global Infant and Child Multiple Vaccine Market Size Forecast by Region
12.1.1 Global Infant and Child Multiple Vaccine Forecast by Region (2024-2029)
12.1.2 Global Infant and Child Multiple Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Infant and Child Multiple Vaccine Forecast by Type
12.7 Global Infant and Child Multiple Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.2.3 GSK Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.4.3 KM Biologics Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.8.3 Minhai Biotechnology Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infant and Child Multiple Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Infant and Child Multiple Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Infant and Child Multiple Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Infant and Child Multiple Vaccine Segment by Type
2.2.1 Pentavalent Vaccine
2.2.2 Quadruple Vaccine
2.2.3 Triple Vaccine
2.2.4 Others
2.3 Infant and Child Multiple Vaccine Sales by Type
2.3.1 Global Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Infant and Child Multiple Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Infant and Child Multiple Vaccine Sale Price by Type (2018-2023)
2.4 Infant and Child Multiple Vaccine Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Infant and Child Multiple Vaccine Sales by Application
2.5.1 Global Infant and Child Multiple Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Infant and Child Multiple Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Infant and Child Multiple Vaccine Sale Price by Application (2018-2023)
3 GLOBAL INFANT AND CHILD MULTIPLE VACCINE BY COMPANY
3.1 Global Infant and Child Multiple Vaccine Breakdown Data by Company
3.1.1 Global Infant and Child Multiple Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Infant and Child Multiple Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Infant and Child Multiple Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Infant and Child Multiple Vaccine Revenue by Company (2018-2023)
3.2.2 Global Infant and Child Multiple Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Infant and Child Multiple Vaccine Sale Price by Company
3.4 Key Manufacturers Infant and Child Multiple Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infant and Child Multiple Vaccine Product Location Distribution
3.4.2 Players Infant and Child Multiple Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFANT AND CHILD MULTIPLE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Infant and Child Multiple Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Infant and Child Multiple Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Infant and Child Multiple Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Infant and Child Multiple Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Infant and Child Multiple Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Infant and Child Multiple Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Infant and Child Multiple Vaccine Sales Growth
4.4 APAC Infant and Child Multiple Vaccine Sales Growth
4.5 Europe Infant and Child Multiple Vaccine Sales Growth
4.6 Middle East & Africa Infant and Child Multiple Vaccine Sales Growth
5 AMERICAS
5.1 Americas Infant and Child Multiple Vaccine Sales by Country
5.1.1 Americas Infant and Child Multiple Vaccine Sales by Country (2018-2023)
5.1.2 Americas Infant and Child Multiple Vaccine Revenue by Country (2018-2023)
5.2 Americas Infant and Child Multiple Vaccine Sales by Type
5.3 Americas Infant and Child Multiple Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infant and Child Multiple Vaccine Sales by Region
6.1.1 APAC Infant and Child Multiple Vaccine Sales by Region (2018-2023)
6.1.2 APAC Infant and Child Multiple Vaccine Revenue by Region (2018-2023)
6.2 APAC Infant and Child Multiple Vaccine Sales by Type
6.3 APAC Infant and Child Multiple Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infant and Child Multiple Vaccine by Country
7.1.1 Europe Infant and Child Multiple Vaccine Sales by Country (2018-2023)
7.1.2 Europe Infant and Child Multiple Vaccine Revenue by Country (2018-2023)
7.2 Europe Infant and Child Multiple Vaccine Sales by Type
7.3 Europe Infant and Child Multiple Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infant and Child Multiple Vaccine by Country
8.1.1 Middle East & Africa Infant and Child Multiple Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Infant and Child Multiple Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Infant and Child Multiple Vaccine Sales by Type
8.3 Middle East & Africa Infant and Child Multiple Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infant and Child Multiple Vaccine
10.3 Manufacturing Process Analysis of Infant and Child Multiple Vaccine
10.4 Industry Chain Structure of Infant and Child Multiple Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infant and Child Multiple Vaccine Distributors
11.3 Infant and Child Multiple Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFANT AND CHILD MULTIPLE VACCINE BY GEOGRAPHIC REGION
12.1 Global Infant and Child Multiple Vaccine Market Size Forecast by Region
12.1.1 Global Infant and Child Multiple Vaccine Forecast by Region (2024-2029)
12.1.2 Global Infant and Child Multiple Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Infant and Child Multiple Vaccine Forecast by Type
12.7 Global Infant and Child Multiple Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.2.3 GSK Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.4.3 KM Biologics Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
13.8.3 Minhai Biotechnology Infant and Child Multiple Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infant and Child Multiple Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Infant and Child Multiple Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Pentavalent Vaccine
Table 4. Major Players of Quadruple Vaccine
Table 5. Major Players of Triple Vaccine
Table 6. Major Players of Others
Table 7. Global Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 8. Global Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Table 9. Global Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2023)
Table 11. Global Infant and Child Multiple Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 13. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Table 14. Global Infant and Child Multiple Vaccine Revenue by Application (2018-2023)
Table 15. Global Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2023)
Table 16. Global Infant and Child Multiple Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global Infant and Child Multiple Vaccine Sales by Company (2018-2023) & (M Doses)
Table 18. Global Infant and Child Multiple Vaccine Sales Market Share by Company (2018-2023)
Table 19. Global Infant and Child Multiple Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Infant and Child Multiple Vaccine Revenue Market Share by Company (2018-2023)
Table 21. Global Infant and Child Multiple Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers Infant and Child Multiple Vaccine Producing Area Distribution and Sales Area
Table 23. Players Infant and Child Multiple Vaccine Products Offered
Table 24. Infant and Child Multiple Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Infant and Child Multiple Vaccine Sales by Geographic Region (2018-2023) & (M Doses)
Table 28. Global Infant and Child Multiple Vaccine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Infant and Child Multiple Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Infant and Child Multiple Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Infant and Child Multiple Vaccine Sales by Country/Region (2018-2023) & (M Doses)
Table 32. Global Infant and Child Multiple Vaccine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Infant and Child Multiple Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Infant and Child Multiple Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
Table 36. Americas Infant and Child Multiple Vaccine Sales Market Share by Country (2018-2023)
Table 37. Americas Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Infant and Child Multiple Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Americas Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 40. Americas Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 41. APAC Infant and Child Multiple Vaccine Sales by Region (2018-2023) & (M Doses)
Table 42. APAC Infant and Child Multiple Vaccine Sales Market Share by Region (2018-2023)
Table 43. APAC Infant and Child Multiple Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Infant and Child Multiple Vaccine Revenue Market Share by Region (2018-2023)
Table 45. APAC Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 46. APAC Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 47. Europe Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
Table 48. Europe Infant and Child Multiple Vaccine Sales Market Share by Country (2018-2023)
Table 49. Europe Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Infant and Child Multiple Vaccine Revenue Market Share by Country (2018-2023)
Table 51. Europe Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 52. Europe Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 53. Middle East & Africa Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
Table 54. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Infant and Child Multiple Vaccine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 58. Middle East & Africa Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 59. Key Market Drivers & Growth Opportunities of Infant and Child Multiple Vaccine
Table 60. Key Market Challenges & Risks of Infant and Child Multiple Vaccine
Table 61. Key Industry Trends of Infant and Child Multiple Vaccine
Table 62. Infant and Child Multiple Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Infant and Child Multiple Vaccine Distributors List
Table 65. Infant and Child Multiple Vaccine Customer List
Table 66. Global Infant and Child Multiple Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 67. Global Infant and Child Multiple Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Infant and Child Multiple Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 69. Americas Infant and Child Multiple Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Infant and Child Multiple Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 71. APAC Infant and Child Multiple Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Infant and Child Multiple Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 73. Europe Infant and Child Multiple Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Infant and Child Multiple Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 75. Middle East & Africa Infant and Child Multiple Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Infant and Child Multiple Vaccine Sales Forecast by Type (2024-2029) & (M Doses)
Table 77. Global Infant and Child Multiple Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Infant and Child Multiple Vaccine Sales Forecast by Application (2024-2029) & (M Doses)
Table 79. Global Infant and Child Multiple Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sanofi Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 82. Sanofi Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Sanofi Main Business
Table 84. Sanofi Latest Developments
Table 85. GSK Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 87. GSK Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Mitsubishi Tanabe Pharma Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 92. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Mitsubishi Tanabe Pharma Main Business
Table 94. Mitsubishi Tanabe Pharma Latest Developments
Table 95. KM Biologics Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. KM Biologics Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 97. KM Biologics Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. KM Biologics Main Business
Table 99. KM Biologics Latest Developments
Table 100. Wuhan Institute of Biological Products Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 102. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Wuhan Institute of Biological Products Main Business
Table 104. Wuhan Institute of Biological Products Latest Developments
Table 105. Walvax Biotechnology Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Walvax Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 107. Walvax Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Walvax Biotechnology Main Business
Table 109. Walvax Biotechnology Latest Developments
Table 110. Chengdu Institute of Biological Products Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 112. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. Chengdu Institute of Biological Products Main Business
Table 114. Chengdu Institute of Biological Products Latest Developments
Table 115. Minhai Biotechnology Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Minhai Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 117. Minhai Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Minhai Biotechnology Main Business
Table 119. Minhai Biotechnology Latest Developments
Table 1. Infant and Child Multiple Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Infant and Child Multiple Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Pentavalent Vaccine
Table 4. Major Players of Quadruple Vaccine
Table 5. Major Players of Triple Vaccine
Table 6. Major Players of Others
Table 7. Global Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 8. Global Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Table 9. Global Infant and Child Multiple Vaccine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2023)
Table 11. Global Infant and Child Multiple Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 13. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Table 14. Global Infant and Child Multiple Vaccine Revenue by Application (2018-2023)
Table 15. Global Infant and Child Multiple Vaccine Revenue Market Share by Application (2018-2023)
Table 16. Global Infant and Child Multiple Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global Infant and Child Multiple Vaccine Sales by Company (2018-2023) & (M Doses)
Table 18. Global Infant and Child Multiple Vaccine Sales Market Share by Company (2018-2023)
Table 19. Global Infant and Child Multiple Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Infant and Child Multiple Vaccine Revenue Market Share by Company (2018-2023)
Table 21. Global Infant and Child Multiple Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers Infant and Child Multiple Vaccine Producing Area Distribution and Sales Area
Table 23. Players Infant and Child Multiple Vaccine Products Offered
Table 24. Infant and Child Multiple Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Infant and Child Multiple Vaccine Sales by Geographic Region (2018-2023) & (M Doses)
Table 28. Global Infant and Child Multiple Vaccine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Infant and Child Multiple Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Infant and Child Multiple Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Infant and Child Multiple Vaccine Sales by Country/Region (2018-2023) & (M Doses)
Table 32. Global Infant and Child Multiple Vaccine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Infant and Child Multiple Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Infant and Child Multiple Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
Table 36. Americas Infant and Child Multiple Vaccine Sales Market Share by Country (2018-2023)
Table 37. Americas Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Infant and Child Multiple Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Americas Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 40. Americas Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 41. APAC Infant and Child Multiple Vaccine Sales by Region (2018-2023) & (M Doses)
Table 42. APAC Infant and Child Multiple Vaccine Sales Market Share by Region (2018-2023)
Table 43. APAC Infant and Child Multiple Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Infant and Child Multiple Vaccine Revenue Market Share by Region (2018-2023)
Table 45. APAC Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 46. APAC Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 47. Europe Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
Table 48. Europe Infant and Child Multiple Vaccine Sales Market Share by Country (2018-2023)
Table 49. Europe Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Infant and Child Multiple Vaccine Revenue Market Share by Country (2018-2023)
Table 51. Europe Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 52. Europe Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 53. Middle East & Africa Infant and Child Multiple Vaccine Sales by Country (2018-2023) & (M Doses)
Table 54. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Infant and Child Multiple Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Infant and Child Multiple Vaccine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Infant and Child Multiple Vaccine Sales by Type (2018-2023) & (M Doses)
Table 58. Middle East & Africa Infant and Child Multiple Vaccine Sales by Application (2018-2023) & (M Doses)
Table 59. Key Market Drivers & Growth Opportunities of Infant and Child Multiple Vaccine
Table 60. Key Market Challenges & Risks of Infant and Child Multiple Vaccine
Table 61. Key Industry Trends of Infant and Child Multiple Vaccine
Table 62. Infant and Child Multiple Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Infant and Child Multiple Vaccine Distributors List
Table 65. Infant and Child Multiple Vaccine Customer List
Table 66. Global Infant and Child Multiple Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 67. Global Infant and Child Multiple Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Infant and Child Multiple Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 69. Americas Infant and Child Multiple Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Infant and Child Multiple Vaccine Sales Forecast by Region (2024-2029) & (M Doses)
Table 71. APAC Infant and Child Multiple Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Infant and Child Multiple Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 73. Europe Infant and Child Multiple Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Infant and Child Multiple Vaccine Sales Forecast by Country (2024-2029) & (M Doses)
Table 75. Middle East & Africa Infant and Child Multiple Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Infant and Child Multiple Vaccine Sales Forecast by Type (2024-2029) & (M Doses)
Table 77. Global Infant and Child Multiple Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Infant and Child Multiple Vaccine Sales Forecast by Application (2024-2029) & (M Doses)
Table 79. Global Infant and Child Multiple Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sanofi Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 82. Sanofi Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Sanofi Main Business
Table 84. Sanofi Latest Developments
Table 85. GSK Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 87. GSK Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Mitsubishi Tanabe Pharma Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 92. Mitsubishi Tanabe Pharma Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Mitsubishi Tanabe Pharma Main Business
Table 94. Mitsubishi Tanabe Pharma Latest Developments
Table 95. KM Biologics Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. KM Biologics Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 97. KM Biologics Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. KM Biologics Main Business
Table 99. KM Biologics Latest Developments
Table 100. Wuhan Institute of Biological Products Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 102. Wuhan Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Wuhan Institute of Biological Products Main Business
Table 104. Wuhan Institute of Biological Products Latest Developments
Table 105. Walvax Biotechnology Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Walvax Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 107. Walvax Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Walvax Biotechnology Main Business
Table 109. Walvax Biotechnology Latest Developments
Table 110. Chengdu Institute of Biological Products Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 112. Chengdu Institute of Biological Products Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. Chengdu Institute of Biological Products Main Business
Table 114. Chengdu Institute of Biological Products Latest Developments
Table 115. Minhai Biotechnology Basic Information, Infant and Child Multiple Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Minhai Biotechnology Infant and Child Multiple Vaccine Product Portfolios and Specifications
Table 117. Minhai Biotechnology Infant and Child Multiple Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Minhai Biotechnology Main Business
Table 119. Minhai Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Infant and Child Multiple Vaccine
Figure 2. Infant and Child Multiple Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infant and Child Multiple Vaccine Sales Growth Rate 2018-2029 (M Doses)
Figure 7. Global Infant and Child Multiple Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Infant and Child Multiple Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Pentavalent Vaccine
Figure 10. Product Picture of Quadruple Vaccine
Figure 11. Product Picture of Triple Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Infant and Child Multiple Vaccine Sales Market Share by Type in 2022
Figure 14. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2023)
Figure 15. Infant and Child Multiple Vaccine Consumed in 12 Months Below
Figure 16. Global Infant and Child Multiple Vaccine Market: 12 Months Below (2018-2023) & (M Doses)
Figure 17. Infant and Child Multiple Vaccine Consumed in 12 Months Above
Figure 18. Global Infant and Child Multiple Vaccine Market: 12 Months Above (2018-2023) & (M Doses)
Figure 19. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2022)
Figure 20. Global Infant and Child Multiple Vaccine Revenue Market Share by Application in 2022
Figure 21. Infant and Child Multiple Vaccine Sales Market by Company in 2022 (M Doses)
Figure 22. Global Infant and Child Multiple Vaccine Sales Market Share by Company in 2022
Figure 23. Infant and Child Multiple Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Infant and Child Multiple Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Infant and Child Multiple Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Infant and Child Multiple Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 28. Americas Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 30. APAC Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 32. Europe Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 34. Middle East & Africa Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Infant and Child Multiple Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Infant and Child Multiple Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Infant and Child Multiple Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Infant and Child Multiple Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Infant and Child Multiple Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Infant and Child Multiple Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Infant and Child Multiple Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Infant and Child Multiple Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Infant and Child Multiple Vaccine
Figure 74. Industry Chain Structure of Infant and Child Multiple Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Infant and Child Multiple Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Infant and Child Multiple Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Infant and Child Multiple Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Infant and Child Multiple Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Infant and Child Multiple Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Infant and Child Multiple Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Infant and Child Multiple Vaccine
Figure 2. Infant and Child Multiple Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infant and Child Multiple Vaccine Sales Growth Rate 2018-2029 (M Doses)
Figure 7. Global Infant and Child Multiple Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Infant and Child Multiple Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Pentavalent Vaccine
Figure 10. Product Picture of Quadruple Vaccine
Figure 11. Product Picture of Triple Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Infant and Child Multiple Vaccine Sales Market Share by Type in 2022
Figure 14. Global Infant and Child Multiple Vaccine Revenue Market Share by Type (2018-2023)
Figure 15. Infant and Child Multiple Vaccine Consumed in 12 Months Below
Figure 16. Global Infant and Child Multiple Vaccine Market: 12 Months Below (2018-2023) & (M Doses)
Figure 17. Infant and Child Multiple Vaccine Consumed in 12 Months Above
Figure 18. Global Infant and Child Multiple Vaccine Market: 12 Months Above (2018-2023) & (M Doses)
Figure 19. Global Infant and Child Multiple Vaccine Sales Market Share by Application (2022)
Figure 20. Global Infant and Child Multiple Vaccine Revenue Market Share by Application in 2022
Figure 21. Infant and Child Multiple Vaccine Sales Market by Company in 2022 (M Doses)
Figure 22. Global Infant and Child Multiple Vaccine Sales Market Share by Company in 2022
Figure 23. Infant and Child Multiple Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Infant and Child Multiple Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Infant and Child Multiple Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Infant and Child Multiple Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 28. Americas Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 30. APAC Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 32. Europe Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Infant and Child Multiple Vaccine Sales 2018-2023 (M Doses)
Figure 34. Middle East & Africa Infant and Child Multiple Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Infant and Child Multiple Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Infant and Child Multiple Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Infant and Child Multiple Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Infant and Child Multiple Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Infant and Child Multiple Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Infant and Child Multiple Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Infant and Child Multiple Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Infant and Child Multiple Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Infant and Child Multiple Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Infant and Child Multiple Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Infant and Child Multiple Vaccine
Figure 74. Industry Chain Structure of Infant and Child Multiple Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Infant and Child Multiple Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Infant and Child Multiple Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Infant and Child Multiple Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Infant and Child Multiple Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Infant and Child Multiple Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Infant and Child Multiple Vaccine Revenue Market Share Forecast by Application (2024-2029)
